Abdulrahman Nasiri: Understanding and Managing Chronic Pain in Transfusion-Dependent Thalassemia
Abdulrahman Nasiri, The Evolving Role of Romiplostim in SAA, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Hemoglobin, adding:
“I am pleased to share our newly published review in Hemoglobin:
The Silent Epidemic: A Scoping Review of Chronic Pain Etiology and Management Strategies in Transfusion-Dependent Thalassemia
Advances in transfusion support and iron chelation have transformed transfusion-dependent thalassemia into a chronic condition. Yet this progress has also revealed an important and often overlooked burden: chronic pain.
Our review found that chronic pain affects approximately 32% to 55% of adults with transfusion-dependent thalassemia, while more than 90% of affected patients report moderate to severe pain.
The causes are multifactorial and include osteoporosis, chelation-related arthropathy, extramedullary hematopoiesis, endocrine dysfunction, fractures, and treatment-related adverse effects.
Despite its clinical impact, pain assessment and management remain inconsistent. We therefore propose a structured, disease-informed approach that integrates validated pain assessment, correction of metabolic and endocrine abnormalities, physical therapy, antiresorptive treatment when indicated, careful selection of analgesics, and optimization of transfusion and iron chelation therapy.
Improving survival is no longer enough. The progress achieved in life expectancy must be matched by meaningful improvements in comfort, daily function, and quality of life.
I am grateful to my coauthors for their valuable contributions and collaboration.”
Title: The Silent Epidemic: A Scoping Review of Chronic Pain Etiology and Management Strategies in Transfusion-Dependent Thalassemia
Authors: Abdulrahman Nasiri ,Mostafa F. Mohammed Saleh ,Manal Alshammari ,Ali Alahmari ,Reem Alkharras ,Fahad Almohareb, Hazza Alzahrani
Other posts featuring Abdulrahman Nasiri on Hemostasis Today.
-
Sep 22, 2026, 19:02Blocking Histone-Induced Platelet-Erythrocyte Interactions With Polyanions – Platelets Journal
-
Sep 22, 2026, 18:49Abdul Rahman Hamad: Early Action for Better Outcomes in Deep Vein Thrombosis
-
Sep 22, 2026, 18:37Carmine Siniscalchi: Age-Adjusted D-Dimer Cutoffs in DVT Diagnosis
-
Sep 22, 2026, 18:37Stefano Romeo: The Cardiovascular Patient Journey is Still Full of Gaps
-
Sep 22, 2026, 18:11Bharath Kumar V.։ Advancing Safer Anticoagulation for Cancer-Associated Thrombosis
-
Sep 22, 2026, 18:10Fatima Zahra: ASH Released New Guidelines on the Diagnosis of Iron Deficiency
-
Sep 22, 2026, 17:49Nirav Dhanesha: Targeting FXI for Safer Anticoagulation
-
Sep 22, 2026, 17:17Eric Lambert: Intravascular Imaging and the Future of Precision PCI
-
Sep 22, 2026, 16:45Claudiu Stoicescu: Are We Starting Cardiovascular Risk Assessment Too Late?